NeuroOne Medical Technologies CorporationNMTCNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank62
3Y CAGR-48.0%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-48.0%/yr
Quarterly compound
Percentile
P62
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.56% |
| Q3 2025 | 67.09% |
| Q2 2025 | 18.65% |
| Q1 2025 | -59.98% |
| Q4 2024 | 1265.99% |
| Q3 2024 | -49.96% |
| Q2 2024 | -27.80% |
| Q1 2024 | 46.60% |
| Q4 2023 | 37.52% |
| Q3 2023 | -20.52% |
| Q2 2023 | 673.47% |
| Q1 2023 | 355.98% |
| Q4 2022 | 18.29% |
| Q3 2022 | -134.87% |
| Q2 2022 | 82.30% |
| Q1 2022 | -176.60% |
| Q4 2021 | 23.55% |
| Q3 2021 | 21.56% |
| Q2 2021 | -3.39% |
| Q1 2021 | 43.91% |
| Q4 2020 | -101.95% |
| Q3 2020 | 530.85% |
| Q2 2020 | -30.71% |
| Q1 2020 | 31.83% |
| Q4 2019 | 67.18% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | -63.70% |